Company Announcements

Representation Agreement Addendum & Warrants Grant

Source: RNS
RNS Number : 1716Q
Quadrise PLC
29 May 2024
 

29 May 2024

Quadrise Plc
("Quadrise" or the "Company")

Addendum to Representation Agreement and Grant of Warrants

 

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, announces that it has signed an addendum (the "Addendum") to the Representation Agreement between Quadrise and Younes Maamar (the "Consultant"), that was originally announced by the Company on 6 March 2019 (the "Agreement").

 

The Agreement, which covers high-level representation services to Quadrise in Morocco, originally provided for the award of a total of 13 million warrants, all of which have expired. Under the new Addendum, the term of the Agreement has been extended to 30 June 2025 and the Consultant will be awarded up to a total of 15.6 million warrants over new ordinary shares in the Company, conditional upon certain key milestones being achieved (the "Addendum Warrants").

 

Following the signature of the Commercial Framework Agreement between Quadrise and OCP,  as announced by the Company on 28 May 2024, an initial tranche of 3.6 million warrants have been awarded to the Consultant (the "Initial Warrants"). The Initial Warrants are exercisable at a price of 1.452 pence per new ordinary share based on the average mid-market closing price of the Company's ordinary shares over a five-day period ending on 24 May 2024 and are exercisable at any point until expiry on 31 May 2025.

 

A second tranche of 12 million warrants will be awarded upon securing a refinery supply source for commercial quantities of MSAR® and the signature of a Commercial MSAR® Fuel Supply Agreement with OCP, by no later than 31 December 2024. On vesting, these warrants may be exercised at any time until 31 December 2025, at which point they expire (the "Conditional Warrants").

 

The Conditional Warrants will have an exercise price of the average mid-market closing price of the Company's ordinary shares over the five-day period ending on the date prior to that on which Quadrise announces signature of a Commercial MSAR® Fuel Supply Agreement for OCP. All other terms of the Agreement remain unchanged.

 

The Addendum Warrants represent 100% of the warrants capable of being issued under the Agreement.

 

For additional information, please contact:

 

Quadrise Plc


+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer






Nominated Adviser



Cavendish Capital Markets Limited


+44 (0)20 7220 0500

Ben Jeynes



Katy Birkin

George Lawson



Joint Brokers

Shore Capital Stockbrokers Limited


 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)



Fiona Conroy (Corporate Broking)



 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)


+44 (0)20 3005 5000




Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay Thomson
Peter Jacob


+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X (formerly Twitter): @QuadrisePlc

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKFBKKBKBCPB